此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Study of Human Microbiota in Healthy and Pathological Conditions (MicroSP)

2018年3月2日 更新者:Istituto Ortopedico Galeazzi

The aim of the present study is to characterize the bacterial composition (microbiota) colonizing to the human body in different physio - pathological conditions (lifestyle, motor activity, surgical operations, probiotic and prebiotic consumption, antibiotic therapies, chemotherapeutic therapies), nervous and musculoskeletal diseases, gastrointestinal and metabolic disorders , oral and vaginal diseases, etc.). In particular, they will be investigate:

  • the changes in the bacterial abundance
  • the potential microbial interactions with the human host
  • the microbial networks describing on the bacterial interactions within a specific composition of the human microbiota

研究概览

地位

未知

条件

干预/治疗

详细说明

The main objective of this study is to deepen the knowledge about the bacterial communities associated to the human organism. In particular, the present study aims to evaluate how the microbiota (intestinal, cutaneous, vaginal, nasal, bronchial, breast milk, salivary, oral, etc.) is subject to quantitative and qualitative changes consequently to different events involving the human host. The project trys to highlight which microorganisms may be involved in the onset or progression of certain pathological condition, as well as to identify which bacterial genera can be more subject to variations due to specific non-pathological events.

Secondary objectives of this study are:

  • To define a "healthy microbiome", that is to understand which are the main bacteria that commonly compose the human microbiome in physiological conditions, differentiating it from that present in certain pathological conditions.
  • To characterize the physiological effects that bacterial changes of the human microbiota have on the host.
  • To evaluate whether the use of probiotics, prebiotics, dietary and nutritional factors, cosmetics, and oral, nasal, vaginal, or pharmacological therapies of any kind can influence the microbial network of the human microbiota associated to different body districts.

研究类型

观察性的

注册 (预期的)

30

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • MI
      • Milan、MI、意大利、20161
        • IRCCS Istituto Ortopedico Galeazzi

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

取样方法

非概率样本

研究人群

For each cohoort 15 healthy subjects will be enrolled (controls), for a total of 90 subjects.

The study involves the recruitment of 180 subjects (90 pathological and 90 healthy and recruited

描述

Inclusion Criteria:

  • subjects suffering from neurological/behavioral diseases;
  • subjects suffering of bone diseases;
  • subjects affected of dysmetabolic / or endocrine disorders;
  • subjects with physical activities at a competitive level;
  • subjects affected of gastrointestinal disorders;
  • subjects with prolonged antibiotic therapies and undergoing surgery

Exclusion Criteria:

  • no use of probiotics in the month prior the sampling;
  • no use of antibiotics in the month prior the sampling;
  • no consumption of yogurt in the month prior the sampling;

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Neurological and behavioral disorders
Subjects with neurological or behavioral disorders such as Tourette syndrome are enrolled.
To evaluate the effects of a specific event (i.e. surgical operation) or therapy (i.e antibiotic treatment) over time;
其他名称:
  • Probiotics, dietary factors, cosmetics and adjuvants
Subjects affected by bone diseases
Subjects affected by bone diseases such as infective osteomyelitis or osteoporosis are enrolled.
To evaluate the effects of a specific event (i.e. surgical operation) or therapy (i.e antibiotic treatment) over time;
其他名称:
  • Probiotics, dietary factors, cosmetics and adjuvants
Dysmetabolic and/or endocrine disorders
Patients with endocrine disorders, such as thyroid disfunctions, or with metabolic disorders, including diabetes mellitus,are enrolled.
Subjects performing agonistic activity
Subjects performing physical activity at agonistic level are enrolled.
Gastroenteric disorders
Subjects affected by gastric and/or enteric disorders are enrolled.
Prolonged antibiotic therapy
Patients subjected to prolonged antibiotic therapies and undergone a variety of surgical procedures are enrolled.
To evaluate the effects of a specific event (i.e. surgical operation) or therapy (i.e antibiotic treatment) over time;
其他名称:
  • Probiotics, dietary factors, cosmetics and adjuvants
Healthy subjects
Subjects without any known ongoing disease are enrolled.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Bacterial abundances calculated by mean of Operational Taxonomic Unit (OTU) count
大体时间:Up to 24 weeks
It is a measure of the bacterial amount
Up to 24 weeks

次要结果测量

结果测量
措施说明
大体时间
Chao's indices estimated on the total OTU amount
大体时间:Up to 24 weeks
It is a measure of bacterial diversity
Up to 24 weeks
Simpson's index (D) estimated on the total OTU amount
大体时间:Up to 24 weeks
It is a measure of bacterial diversity
Up to 24 weeks
Shannon's index estimated on the total OTU amount
大体时间:Up to 24 weeks
It is a measure of bacterial diversity
Up to 24 weeks
The OTU abundances will be used to calculate an adjacency matrix based on the Spearman's correlation coefficient (rs) among different bacterial genus
大体时间:up to 24 weeks
It is a measure of strength of linear association between different bacterial genera
up to 24 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

调查人员

  • 首席研究员:Lorenzo Drago, Prof.、IRCCS Galeazzi Orthopedic Institute, Milan, Italy

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2017年6月12日

初级完成 (实际的)

2017年7月31日

研究完成 (预期的)

2019年12月31日

研究注册日期

首次提交

2018年2月15日

首先提交符合 QC 标准的

2018年3月2日

首次发布 (实际的)

2018年3月9日

研究记录更新

最后更新发布 (实际的)

2018年3月9日

上次提交的符合 QC 标准的更新

2018年3月2日

最后验证

2018年2月1日

更多信息

与本研究相关的术语

关键字

其他研究编号

  • MiscoSP

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.